SVB Leerink Maintains Outperform on Agilon Health, Lowers Price Target to $25
SVB Leerink analyst Whit Mayo maintains Agilon Health (NYSE:AGL) with a Outperform and lowers the price target from $35 to $25.
Agilon Health’s Return On Capital Employed Overview
Benzinga Pro data, Agilon Health (NYSE:AGL) reported Q4 sales of $462.89 million. Earnings fell to a loss of $56.74 million, resulting in a 57.79% decrease from last quarter.
68 Biggest Movers From Friday
Gainers
Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 101.8% to close at $40.77 on Friday after jumping 39% on Thursday.
Mid-Afternoon Market Update: Crude Oil Rises Over 6%; VIZIO Shares Slide
U.S. stocks remained lower toward the end of trading, with the Nasdaq dropping over 200 points on Friday.
43 Stocks Moving In Friday’s Mid-Day Session
Gainers
VEON Ltd. (NASDAQ: VEON) rose 45.6% to $0.3830 after dropping 41% on Thursday.
Agilon Health Q4 EPS $(0.14) Misses $(0.11) Estimate, Sales $463.00M Beat $452.89M Estimate
Agilon Health (NYSE:AGL) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.11) by 27.27 percent. The company reported quarterly sales of $463.00 million which beat the
Earnings Scheduled For March 3, 2022
Companies Reporting Before The Bell
• Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.
agilon health To Host Investor Day On March 11
The company will also report fourth quarter and fiscal year 2021 results on March 3
AUSTIN, Texas--(BUSINESS WIRE)-- agilon health, inc. (NYSE:AGL), the company transforming health care for seniors by empowering
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Deutsche Bank Maintains Buy on Agilon Health, Lowers Price Target to $30
Deutsche Bank analyst George Hill maintains Agilon Health (NYSE:AGL) with a Buy and lowers the price target from $36 to $30.